Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free NEOG Stock Alerts

Neogen (NEOG) Competitors

Neogen logo
$11.86 +0.15 (+1.26%)
Closing price 03:59 PM Eastern
Extended Trading
$11.84 -0.01 (-0.10%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

NEOG vs. COO, ALGN, BLCO, MMSI, and ICUI

Should you buy Neogen stock or one of its competitors? Neogen's main competitors and comparable companies include Cooper Companies (COO), Align Technology (ALGN), Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), and ICU Medical (ICUI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Neogen compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Cooper Companies has a net margin of 13.46% compared to Neogen's net margin of -6.35%. Cooper Companies' return on equity of 10.90% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Neogen -6.35%3.29%2.06%

Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Neogen has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

In the previous week, Neogen had 9 more articles in the media than Cooper Companies. MarketBeat recorded 45 mentions for Neogen and 36 mentions for Cooper Companies. Neogen's average media sentiment score of 0.53 beat Cooper Companies' score of 0.15 indicating that Neogen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
7 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Neogen
10 Very Positive mention(s)
10 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.52$374.90M$2.9318.53
Neogen$870.40M2.93-$7.90M-$0.03N/A

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 0.5% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cooper Companies currently has a consensus target price of $68.60, suggesting a potential upside of 26.34%. Neogen has a consensus target price of $12.67, suggesting a potential upside of 8.17%. Given Cooper Companies' higher possible upside, research analysts plainly believe Cooper Companies is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Cooper Companies beats Neogen on 10 of the 16 factors compared between the two stocks.

How does Neogen compare to Align Technology?

Neogen (NASDAQ:NEOG) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

96.7% of Neogen shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.5% of Neogen shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Align Technology has a net margin of 9.99% compared to Neogen's net margin of -6.35%. Align Technology's return on equity of 15.86% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-6.35% 3.29% 2.06%
Align Technology 9.99%15.86%10.32%

Align Technology has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$870.40M2.93-$7.90M-$0.03N/A
Align Technology$4.03B2.50$410.35M$5.7524.53

Neogen currently has a consensus target price of $12.67, indicating a potential upside of 8.17%. Align Technology has a consensus target price of $201.71, indicating a potential upside of 43.03%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Align Technology
0 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.63

Neogen has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

In the previous week, Neogen had 34 more articles in the media than Align Technology. MarketBeat recorded 45 mentions for Neogen and 11 mentions for Align Technology. Neogen's average media sentiment score of 0.53 beat Align Technology's score of 0.42 indicating that Neogen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
10 Very Positive mention(s)
10 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Align Technology beats Neogen on 12 of the 17 factors compared between the two stocks.

How does Neogen compare to Bausch + Lomb?

Neogen (NASDAQ:NEOG) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

In the previous week, Neogen had 35 more articles in the media than Bausch + Lomb. MarketBeat recorded 45 mentions for Neogen and 10 mentions for Bausch + Lomb. Neogen's average media sentiment score of 0.53 beat Bausch + Lomb's score of 0.31 indicating that Neogen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
10 Very Positive mention(s)
10 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch + Lomb
1 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.7% of Neogen shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 0.5% of Neogen shares are held by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Neogen currently has a consensus target price of $12.67, suggesting a potential upside of 8.17%. Bausch + Lomb has a consensus target price of $19.46, suggesting a potential upside of 13.38%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts clearly believe Bausch + Lomb is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Bausch + Lomb
1 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47

Neogen has higher earnings, but lower revenue than Bausch + Lomb. Neogen is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$870.40M2.93-$7.90M-$0.03N/A
Bausch + Lomb$5.10B1.20-$360M-$0.48N/A

Neogen has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Bausch + Lomb has a net margin of -3.21% compared to Neogen's net margin of -6.35%. Bausch + Lomb's return on equity of 4.14% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-6.35% 3.29% 2.06%
Bausch + Lomb -3.21%4.14%1.93%

Summary

Bausch + Lomb beats Neogen on 9 of the 17 factors compared between the two stocks.

How does Neogen compare to Merit Medical Systems?

Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Neogen has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to Neogen's net margin of -6.35%. Merit Medical Systems' return on equity of 13.75% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-6.35% 3.29% 2.06%
Merit Medical Systems 9.22%13.75%8.10%

Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$870.40M2.93-$7.90M-$0.03N/A
Merit Medical Systems$1.52B3.36$128.49M$2.4235.23

Neogen presently has a consensus price target of $12.67, suggesting a potential upside of 8.17%. Merit Medical Systems has a consensus price target of $100.00, suggesting a potential upside of 17.30%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83

In the previous week, Neogen had 43 more articles in the media than Merit Medical Systems. MarketBeat recorded 45 mentions for Neogen and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.58 beat Neogen's score of 0.53 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
10 Very Positive mention(s)
10 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.5% of Neogen shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Merit Medical Systems beats Neogen on 15 of the 17 factors compared between the two stocks.

How does Neogen compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Neogen (NASDAQ:NEOG) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

ICU Medical has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Neogen has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

ICU Medical currently has a consensus price target of $192.80, suggesting a potential upside of 22.66%. Neogen has a consensus price target of $12.67, suggesting a potential upside of 8.17%. Given ICU Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe ICU Medical is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

ICU Medical has a net margin of 1.39% compared to Neogen's net margin of -6.35%. ICU Medical's return on equity of 7.91% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Neogen -6.35%3.29%2.06%

ICU Medical has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.76$730K$1.18133.20
Neogen$870.40M2.93-$7.90M-$0.03N/A

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 0.5% of Neogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Neogen had 43 more articles in the media than ICU Medical. MarketBeat recorded 45 mentions for Neogen and 2 mentions for ICU Medical. Neogen's average media sentiment score of 0.53 beat ICU Medical's score of 0.51 indicating that Neogen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Neogen
10 Very Positive mention(s)
10 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

ICU Medical beats Neogen on 12 of the 17 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

Export
MetricNeogenHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.60B$5.44B$7.20B$13.28B
Dividend YieldN/A1.78%2.53%16.36%
P/E Ratio-47.6225.46274.5426.18
Price / Sales2.9470.40585.6081.39
Price / Cash13.8532.1076.8253.72
Price / Book1.245.9311.216.33
Net Income-$7.90M$146.18M$3.50B$381.90M
7 Day Performance-2.02%-0.40%-0.68%-1.27%
1 Month Performance-0.13%-3.34%-5.29%-4.19%
1 Year Performance75.59%2.75%4.62%-0.21%

Neogen Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
2.3461 of 5 stars		$11.86
+1.3%		$12.67
+6.8%		+101.2%$2.59B$884MN/A1,257
COO
Cooper Companies
4.2959 of 5 stars		$56.57
+2.1%		$71.47
+26.3%		-22.7%$10.53B$4.09B19.3115,000
ALGN
Align Technology
4.0087 of 5 stars		$145.00
-1.2%		$206.36
+42.3%		+6.0%$10.51B$4.03B25.2220,290
BLCO
Bausch + Lomb
4.2123 of 5 stars		$16.95
+0.5%		$19.15
+13.0%		+16.5%$6.02B$5.10BN/A13,000
MMSI
Merit Medical Systems
3.1139 of 5 stars		$87.00
-0.6%		$100.00
+14.9%		+1.8%$5.22B$1.52B35.957,500

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NEOG) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel